Theratechnologies Incorporated

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Theratechnologies is a Canadian biopharmaceutical company engaged in the field of therapeutic peptides targeting endocrine and metabolic disorders. Through its subsidiary, Celmed BioSciences, the Company is also active in the field of cell therapy using adult stem cells.

Contact Details: 630 Rene-Levesque Boulevard West 5th Floor Montreal Quebec H3B 1S6 Canada Tel: 514 877 0077 Fax: 514 877 3177 Email: webinfo@theratech.com WWW: www.thrt.com/

Loading...

Recent Publications by Theratechnologies Incorporated:
Sequential design approaches for bioequivalence studies with crossover designs. The planning of bioequivalence (BE) studies, as for any clinical trial,...	22nd August, 2007	Theratechnologies Inc., Montreal, Que., Canada.	Pharm Stat. 2007 Aug 20. DOI Direct Link
Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue. TH9507, an analogue of human growth hormone-releasing factor (hGRF1-44NH2)...	16th March, 2007	Theratechnologies Inc., 2310 Boulevard Alfred Nobel, Montreal, QC, Canada.	Basic Clin Pharmacol Toxicol. 2007 Jan;100(1):49-58. DOI Direct Link

BioNews Results for Theratechnologies Incorporated:
CryoCath Deal Stirs M&A Talk In Canada's Biotech Sector	Wall Street Journal Online:  Sep 26 2008 6:53PM Matching: theratechnologies
Human Growth Hormone: How It Can (and Can't) Help With Body Shape Changes	The Body:  Sep 25 2008 9:10AM Matching: theratechnologies
Theratechnologies to Present at UBS Global Life Sciences Conference	Pharma Live:  Sep 18 2008 7:31PM Matching: theratechnologies
Long-term Safety and Effectiveness of Growth Hormone Releasing Factor Tesamorelin for Lipodystrophy	HIV and Hepatitis.com:  Sep 17 2008 5:35AM Matching: theratechnologies
Theratechnologies announces publication in AIDS	Bioscience World/Biotechnology Focus:  Sep 5 2008 6:41PM Matching: theratechnologies
Promote your company here: BioNewsCast - Press Release Distribution	→View more Theratechnologies Incorporated news.

Theratechnologies Incorporated Patents:
US Patent No.	Title
7414029	Antagonistic peptides of prostaglandin E2 receptor subtype EP4
5798523	Irradiating apparatus using a scanning light source for photodynamic treatment
5817627	Long-acting galenical formulation for GRF peptides
5834418	Process for the preparation of platelet growth factors extract
5837204	System for disinfecting the water lines of a dental unit
→View more Theratechnologies Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 239 times since April 2007, the link to the organisation's website has been followed 60 times

Recent Search Terms used to find this page: theratechnologies | theratech | celmed levesque press release | theratechnologies | theratechnologies | theratechnologies | THERATECHNOLOGIES INCORPORATED | platelet extract theratechnologies | theratechnologies | .

Search for more companies in Montreal

Search for more companies in Quebec

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Theratechnologies Incorporated

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.